Erez Vigodman

2015

In 2015, Erez Vigodman earned a total compensation of $7.4M as Former President and CEO at Teva Pharmaceutical Industries.

Compensation breakdown

Non-Equity Incentive Plan$2,253,581
Option Awards$1,650,060
Salary$1,363,692
Stock Awards$1,649,948
Other$435,942
Total$7,353,223

Vigodman received $2.3M in non-equity incentive plan, accounting for 31% of the total pay in 2015.

Vigodman also received $1.7M in option awards, $1.4M in salary, $1.6M in stock awards and $435.9K in other compensation.

Rankings

In 2015, Erez Vigodman's compensation ranked 904th out of 13,638 executives tracked by ExecPay. In other words, Vigodman earned more than 93.4% of executives.

ClassificationRankingPercentile
All
904
out of 13,638
93rd
Division
Manufacturing
311
out of 5,187
94th
Major group
Chemicals And Allied Products
113
out of 1,857
94th
Industry group
Drugs
87
out of 1,531
94th
Industry
Pharmaceutical Preparations
71
out of 1,179
94th
Source: SEC filing on April 25, 2018.

Vigodman's colleagues

We found three more compensation records of executives who worked with Erez Vigodman at Teva Pharmaceutical Industries in 2015.

2015

Michael Hayden

Teva Pharmaceutical Industries

Chief Scientific Officer

2015

Carlo de Notaristefani

Teva Pharmaceutical Industries

Executive Vice President, Global Operations

2015

Eyal Desheh

Teva Pharmaceutical Industries

Chief Financial Officer

You may also like